drugset / Trial / NCT01641796

Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis

NCT01641796 ↗

Expanded access No longer available U.S. Army Medical Research and Development Command

Summary

This is an expanded access treatment protocol designed to provide a topical cream treatment option to military health care beneficiaries with parasitologically confirmed uncomplicated Cutaneous Leishmaniasis.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Paromomycin Small molecule — Topical